<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35347633</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-6903</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>47</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Neurochemical research</Title>
          <ISOAbbreviation>Neurochem Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Enhanced Cortical Metabolic Activity in Females and Males of a Slow Progressing Mouse Model of Amyotrophic Lateral Sclerosis.</ArticleTitle>
        <Pagination>
          <StartPage>1765</StartPage>
          <EndPage>1777</EndPage>
          <MedlinePgn>1765-1777</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11064-022-03568-2</ELocationID>
        <Abstract>
          <AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder with selective degeneration of motor neurons in the central nervous system. The pathophysiology of ALS is not well understood. We have used <sup>1</sup>H-[<sup>13</sup>C]-NMR spectroscopy together with an administration of [1,6-<sup>13</sup>C<sub>2</sub>]glucose and [2-<sup>13</sup>C]acetate in female and male SOD1<sup>G37R</sup> mice to assess neuronal and astroglial metabolic activity, respectively, in the central nervous system in ALS condition. The female (p = 0.0008) and male (p &lt; 0.0001) SOD1<sup>G37R</sup> mice exhibited decreased forelimb strength when compared with wild-type mice. There was a reduction in N-acetylaspartylglutamate level, and elevation in myo-inositol in the spinal cord of female and male SOD1<sup>G37R</sup> mice. The transgenic male mice exhibited increased acetate oxidation in the spinal cord (p = 0.05) and cerebral cortex (p = 0.03), while females showed an increase in the spinal cord (p = 0.02) only. As acetate is transported and preferentially metabolized in the astrocytes, the finding of increased rate of acetate oxidation in the transgenic mice is suggestive of astrocytic involvement in the pathogenesis of ALS. The rates of glucose oxidation in glutamatergic (p = 0.0004) and GABAergic neurons (p = 0.0052) were increased in the cerebral cortex of male SOD1<sup>G37R</sup> mice when compared with the controls. The female mice showed an increase in glutamatergic (p = 0.039) neurometabolic activity only. The neurometabolic activity was unperturbed in the spinal cord of either sex. These data suggest differential changes in neurometabolic activity across the central nervous system in SOD1<sup>G37R</sup> mice.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Roy</LastName>
            <ForeName>Dipak</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>NMR Microimaging and Spectroscopy, CSIR-Centre for Cellular and Molecular Biology, Habsiguda, Uppal Road, Hyderabad, 500007, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Puvvada</LastName>
            <ForeName>Madhuri</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>NMR Microimaging and Spectroscopy, CSIR-Centre for Cellular and Molecular Biology, Habsiguda, Uppal Road, Hyderabad, 500007, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kapanaiah</LastName>
            <ForeName>Sampath K T</ForeName>
            <Initials>SKT</Initials>
            <AffiliationInfo>
              <Affiliation>NMR Microimaging and Spectroscopy, CSIR-Centre for Cellular and Molecular Biology, Habsiguda, Uppal Road, Hyderabad, 500007, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Patel</LastName>
            <ForeName>Anant Bahadur</ForeName>
            <Initials>AB</Initials>
            <AffiliationInfo>
              <Affiliation>NMR Microimaging and Spectroscopy, CSIR-Centre for Cellular and Molecular Biology, Habsiguda, Uppal Road, Hyderabad, 500007, India. abpatel@ccmb.res.in.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Academy of Scientific and Innovative Research, Ghaziabad, 201002, India. abpatel@ccmb.res.in.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Neurochem Res</MedlineTA>
        <NlmUniqueID>7613461</NlmUniqueID>
        <ISSNLinking>0364-3190</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 1.15.1.1</RegistryNumber>
          <NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.15.1.1</RegistryNumber>
          <NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>IY9XDZ35W2</RegistryNumber>
          <NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cerebral cortex</Keyword>
        <Keyword MajorTopicYN="N">GABA</Keyword>
        <Keyword MajorTopicYN="N">Glutamate</Keyword>
        <Keyword MajorTopicYN="N">Neurometabolism</Keyword>
        <Keyword MajorTopicYN="N">Spinal cord</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>29</Day>
          <Hour>5</Hour>
          <Minute>48</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35347633</ArticleId>
        <ArticleId IdType="doi">10.1007/s11064-022-03568-2</ArticleId>
        <ArticleId IdType="pii">10.1007/s11064-022-03568-2</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Taylor JP, Brown RH Jr, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539:197–206</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27830784</ArticleId>
            <ArticleId IdType="pmc">5585017</ArticleId>
            <ArticleId IdType="doi">10.1038/nature20413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robberecht W, Philips T (2013) The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 14:248–264</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23463272</ArticleId>
            <ArticleId IdType="doi">10.1038/nrn3430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nicholls DG (1989) Release of glutamate, aspartate, and gamma-aminobutyric acid from isolated nerve terminals. J Neurochem 52:331–341</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2562986</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1471-4159.1989.tb09126.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nicholls DG (1993) The glutamatergic nerve terminal. Eur J Biochem 212:613–631</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8096460</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1432-1033.1993.tb17700.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Graaf RA, Brown PB, Mason GF, Rothman DL, Behar KL (2003) Detection of [1,6–<sup>13</sup>C<sub>2</sub>]-glucose metabolism in rat brain by in vivo <sup>1</sup>H-[<sup>13</sup>C]-NMR spectroscopy. Magn Reson Med 49:37–46</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12509818</ArticleId>
            <ArticleId IdType="doi">10.1002/mrm.10348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Graaf RA, Mason GF, Patel AB, Behar KL, Rothman DL (2003) In vivo <sup>1</sup>H-[<sup>13</sup>C]-NMR spectroscopy of cerebral metabolism. NMR Biomed 16:339–357</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14679499</ArticleId>
            <ArticleId IdType="doi">10.1002/nbm.847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel AB, de Graaf RA, Rothman DL, Behar KL, Mason GF (2010) Evaluation of cerebral acetate transport and metabolic rates in the rat brain in vivo using <sup>1</sup>H-[<sup>13</sup>C]-NMR. J Cereb Blood Flow Metab 30:1200–1213</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20125180</ArticleId>
            <ArticleId IdType="pmc">2879471</ArticleId>
            <ArticleId IdType="doi">10.1038/jcbfm.2010.2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sibson NR, Dhankhar A, Mason GF, Rothman DL, Behar KL, Shulman RG (1998) Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci U S A 95:316–321</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9419373</ArticleId>
            <ArticleId IdType="pmc">18211</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.95.1.316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hyder F, Patel AB, Gjedde A, Rothman DL, Behar KL, Shulman RG (2006) Neuronal-glial glucose oxidation and glutamatergic-GABAergic function. J Cereb Blood Flow Metab 26:865–877</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16407855</ArticleId>
            <ArticleId IdType="doi">10.1038/sj.jcbfm.9600263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel AB, de Graaf RA, Mason GF, Kanamatsu T, Rothman DL, Shulman RG, Behar KL (2004) Glutamatergic neurotransmission and neuronal glucose oxidation are coupled during intense neuronal activation. J Cereb Blood Flow Metab 24:972–985</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15356418</ArticleId>
            <ArticleId IdType="doi">10.1097/01.WCB.0000126234.16188.71</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abdallah CG, Jiang L, De Feyter HM, Fasula M, Krystal JH, Rothman DL, Mason GF, Sanacora G (2014) Glutamate metabolism in major depressive disorder. Am J Psychiatry 171:1320–1327</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25073688</ArticleId>
            <ArticleId IdType="pmc">4472484</ArticleId>
            <ArticleId IdType="doi">10.1176/appi.ajp.2014.14010067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bagga P, Chugani AN, Varadarajan KS, Patel AB (2013) In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson’s disease: recovery of cerebral metabolism with acute levodopa treatment. J Neurochem 127:365–377</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23957451</ArticleId>
            <ArticleId IdType="doi">10.1111/jnc.12407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nilsen LH, Witter MP, Sonnewald U (2014) Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer’s disease. J Cereb Blood Flow Metab 34:906–914</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24594625</ArticleId>
            <ArticleId IdType="pmc">4013773</ArticleId>
            <ArticleId IdType="doi">10.1038/jcbfm.2014.37</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tiwari V, Saba K, Veeraiah P, Jose J, Lakhotia SC, Patel AB (2017) Amalaki Rasayana improved memory and neuronal metabolic activity in AbPP-PS1 mouse model of Alzheimer’s disease. J Biosci 42:363–371</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29358550</ArticleId>
            <ArticleId IdType="doi">10.1007/s12038-017-9692-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Zijden JP, van Eijsden P, de Graaf RA, Dijkhuizen RM (2008) 1H/13C MR spectroscopic imaging of regionally specific metabolic alterations after experimental stroke. Brain 131:2209–2219</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18669496</ArticleId>
            <ArticleId IdType="doi">10.1093/brain/awn139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veeraiah P, Noronha JM, Maitra S, Bagga P, Khandelwal N, Chakravarty S, Kumar A, Patel AB (2014) Dysfunctional glutamatergic and gamma-aminobutyric acidergic activities in prefrontal cortex of mice in social defeat model of depression. Biol Psychiatry 76:231–238</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24239130</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopsych.2013.09.024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corona JC, Tovar-y-Romo LB, Tapia R (2007) Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis. Expert Opin Ther Targets 11:1415–1428</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18028007</ArticleId>
            <ArticleId IdType="doi">10.1517/14728222.11.11.1415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ (2011) Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 7:616–630</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22051914</ArticleId>
            <ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersen JV, Markussen KH, Jakobsen E, Schousboe A, Waagepetersen HS, Rosenberg PA, Aldana BI (2021) Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration. Neuropharmacology 196:108719</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34273389</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuropharm.2021.108719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bak LK, Schousboe A, Waagepetersen HS (2006) The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 98:641–653</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16787421</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1471-4159.2006.03913.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Govind V, Sharma KR, Maudsley AA, Arheart KL, Saigal G, Sheriff S (2012) Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy. PLoS ONE 7:e35607</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22539984</ArticleId>
            <ArticleId IdType="pmc">3335096</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0035607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rule RR, Suhy J, Schuff N, Gelinas DF, Miller RG, Weiner MW (2004) Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph Lateral Scler Other Motor Neuron Disord 5:141–149</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15512902</ArticleId>
            <ArticleId IdType="pmc">2744639</ArticleId>
            <ArticleId IdType="doi">10.1080/14660820410017109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sudharshan N, Hanstock C, Hui B, Pyra T, Johnston W, Kalra S (2011) Degeneration of the mid-cingulate cortex in amyotrophic lateral sclerosis detected in vivo with MR spectroscopy. AJNR Am J Neuroradiol 32:403–407</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21087934</ArticleId>
            <ArticleId IdType="pmc">7965735</ArticleId>
            <ArticleId IdType="doi">10.3174/ajnr.A2289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niessen HG, Debska-Vielhaber G, Sander K, Angenstein F, Ludolph AC, Hilfert L, Willker W, Leibfritz D, Heinze HJ, Kunz WS, Vielhaber S (2007) Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 25:1669–1677</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17432958</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1460-9568.2007.05415.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi JK, Kustermann E, Dedeoglu A, Jenkins BG (2009) Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation. Eur J Neurosci 30:2143–2150</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19930399</ArticleId>
            <ArticleId IdType="pmc">2846694</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1460-9568.2009.07015.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cistaro A, Valentini MC, Chio A, Nobili F, Calvo A, Moglia C, Montuschi A, Morbelli S, Salmaso D, Fania P, Carrara G, Pagani M (2012) Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging 39:251–259</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22089661</ArticleId>
            <ArticleId IdType="doi">10.1007/s00259-011-1979-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ludolph AC, Langen KJ, Regard M, Herzog H, Kemper B, Kuwert T, Bottger IG, Feinendegen L (1992) Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand 85:81–89</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1574993</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1600-0404.1992.tb04003.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pagani M, Chio A, Valentini MC, Oberg J, Nobili F, Calvo A, Moglia C, Bertuzzo D, Morbelli S, De Carli F, Fania P, Cistaro A (2014) Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis. Neurology 83:1067–1074</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25122207</ArticleId>
            <ArticleId IdType="doi">10.1212/WNL.0000000000000792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I (2006) Gender differences in neurological disease: role of estrogens and cytokines. Endocrine 29:243–256</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16785600</ArticleId>
            <ArticleId IdType="doi">10.1385/ENDO:29:2:243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pape JA, Grose JH (2020) The effects of diet and sex in amyotrophic lateral sclerosis. Rev Neurol (Paris) 176:301–315</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neurol.2019.09.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCombe PA, Henderson RD (2010) Effects of gender in amyotrophic lateral sclerosis. Gend Med 7:557–570</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21195356</ArticleId>
            <ArticleId IdType="doi">10.1016/j.genm.2010.11.010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ezzi SA, Lariviere R, Urushitani M, Julien JP (2010) Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS. J Neurochem 115:1102–1111</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20807312</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1471-4159.2010.06979.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fitzpatrick SM, Hetherington HP, Behar KL, Shulman RG (1990) The flux from glucose to glutamate in the rat brain in vivo as determined by <sup>1</sup>H-observed, <sup>13</sup>C-edited NMR spectroscopy. J Cereb Blood Flow Metab 10:170–179</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1968068</ArticleId>
            <ArticleId IdType="doi">10.1038/jcbfm.1990.32</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel AB, Rothman DL, Cline GW, Behar KL (2001) Glutamine is the major precursor for GABA synthesis in rat neocortex in vivo following acute GABA-transaminase inhibition. Brain Res 919:207–220</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11701133</ArticleId>
            <ArticleId IdType="doi">10.1016/S0006-8993(01)03015-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rae C, Fekete AD, Kashem MA, Nasrallah FA, Broer S (2012) Metabolism, compartmentation, transport and production of acetate in the cortical brain tissue slice. Neurochem Res 37:2541–2553</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22851350</ArticleId>
            <ArticleId IdType="doi">10.1007/s11064-012-0847-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Waniewski RA, Martin DL (1998) Preferential utilization of acetate by astrocytes is attributable to transport. J Neurosci 18:5225–5233</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9651205</ArticleId>
            <ArticleId IdType="pmc">6793490</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.18-14-05225.1998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hassel B, Bachelard H, Jones P, Fonnum F, Sonnewald U (1997) Trafficking of amino acids between neurons and glia in vivo. Effects of inhibition of glial metabolism by fluoroacetate. J Cereb Blood Flow Metab 17:1230–1238</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9390655</ArticleId>
            <ArticleId IdType="doi">10.1097/00004647-199711000-00012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lebon V, Petersen KF, Cline GW, Shen J, Mason GF, Dufour S, Behar KL, Shulman GI, Rothman DL (2002) Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J Neurosci 22:1523–1531</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11880482</ArticleId>
            <ArticleId IdType="pmc">2995528</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.22-05-01523.2002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mishra PK, Adusumilli M, Deolal P, Mason GF, Kumar A, Patel AB (2020) Impaired neuronal and astroglial metabolic activity in chronic unpredictable mild stress model of depression: reversal of behavioral and metabolic deficit with lanicemine. Neurochem Int 137:104750</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32360130</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuint.2020.104750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel AB, de Graaf RA, Mason GF, Rothman DL, Shulman RG, Behar KL (2005) The contribution of GABA to glutamate/glutamine cycling and energy metabolism in the rat cortex in vivo. Proc Natl Acad Sci USA 102:5588–5593</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15809416</ArticleId>
            <ArticleId IdType="pmc">556230</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.0501703102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dalakas MC, Hatazawa J, Brooks RA, Di Chiro G (1987) Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Ann Neurol 22:580–586</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3501273</ArticleId>
            <ArticleId IdType="doi">10.1002/ana.410220504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atassi N, Xu M, Triantafyllou C, Keil B, Lawson R, Cernasov P, Ratti E, Long CJ, Paganoni S, Murphy A, Salibi N, Seethamraju R, Rosen B, Ratai EM (2017) Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis. PLoS ONE 12:e0177680</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28498852</ArticleId>
            <ArticleId IdType="pmc">5428977</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0177680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weerasekera A, Sima DM, Dresselaers T, Van Huffel S, Van Damme P, Himmelreich U (2018) Non-invasive assessment of disease progression and neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1(G93A) mouse model: A (1)H-magnetic resonance spectroscopic study. Neuroimage Clin 20:1092–1105</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30368196</ArticleId>
            <ArticleId IdType="pmc">6202692</ArticleId>
            <ArticleId IdType="doi">10.1016/j.nicl.2018.09.011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lei H, Dirren E, Poitry-Yamate C, Schneider BL, Gruetter R, Aebischer P (2019) Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J Cereb Blood Flow Metab 39:1283–1298</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29400109</ArticleId>
            <ArticleId IdType="doi">10.1177/0271678X18756499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Filibian M, Frasca A, Maggioni D, Micotti E, Vezzani A, Ravizza T (2012) In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity. Epilepsia 53:1907–1916</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23030308</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1528-1167.2012.03685.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burg MB, Ferraris JD (2008) Intracellular organic osmolytes: function and regulation. J Biol Chem 283:7309–7313</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18256030</ArticleId>
            <ArticleId IdType="pmc">2276334</ArticleId>
            <ArticleId IdType="doi">10.1074/jbc.R700042200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tefera TW, Borges K (2019) Neuronal glucose metabolism is impaired while astrocytic TCA cycling is unaffected at symptomatic stages in the hSOD1(G93A) mouse model of amyotrophic lateral sclerosis. J Cereb Blood Flow Metab 39:1710–1724</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29553298</ArticleId>
            <ArticleId IdType="doi">10.1177/0271678X18764775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sugiyama M, Takao M, Hatsuta H, Funabe S, Ito S, Obi T, Tanaka F, Kuroiwa Y, Murayama S (2013) Increased number of astrocytes and macrophages/microglial cells in the corpus callosum in amyotrophic lateral sclerosis. Neuropathology 33:591–599</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23530811</ArticleId>
            <ArticleId IdType="doi">10.1111/neup.12027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dahlke C, Saberi D, Ott B, Brand-Saberi B, Schmitt-John T, Theiss C (2015) Inflammation and neuronal death in the motor cortex of the wobbler mouse, an ALS animal model. J Neuroinflammation 12:215</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26597538</ArticleId>
            <ArticleId IdType="pmc">4657283</ArticleId>
            <ArticleId IdType="doi">10.1186/s12974-015-0435-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marik J, Ogasawara A, Martin-McNulty B, Ross J, Flores JE, Gill HS, Tinianow JN, Vanderbilt AN, Nishimura M, Peale F, Pastuskovas C, Greve JM, van Bruggen N, Williams SP (2009) PET of glial metabolism using 2–18F-fluoroacetate. J Nucl Med 50:982–990</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19443600</ArticleId>
            <ArticleId IdType="doi">10.2967/jnumed.108.057356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cardona-Rossinyol A, Mir M, Caraballo-Miralles V, Llado J, Olmos G (2013) Neuroprotective effects of estradiol on motoneurons in a model of rat spinal cord embryonic explants. Cell Mol Neurobiol 33:421–432</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23322321</ArticleId>
            <ArticleId IdType="doi">10.1007/s10571-013-9908-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi CI, Lee YD, Gwag BJ, Cho SI, Kim SS, Suh-Kim H (2008) Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice. J Neurol Sci 268:40–47</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18054961</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jns.2007.10.024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan L, Liu Y, Sun C, Zheng Q, Hao P, Zhai J, Liu Y (2018) Effects of ovariectomy in an hSOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis (ALS). Med Sci Monit 24:678–686</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29394243</ArticleId>
            <ArticleId IdType="pmc">5806477</ArticleId>
            <ArticleId IdType="doi">10.12659/MSM.908786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vucic S, Cheah BC, Kiernan MC (2009) Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis. Exp Neurol 220:177–182</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19716820</ArticleId>
            <ArticleId IdType="doi">10.1016/j.expneurol.2009.08.017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomsen GM, Gowing G, Latter J, Chen M, Vit JP, Staggenborg K, Avalos P, Alkaslasi M, Ferraiuolo L, Likhite S, Kaspar BK, Svendsen CN (2014) Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. J Neurosci 34:15587–15600</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25411487</ArticleId>
            <ArticleId IdType="pmc">4298650</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2037-14.2014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ozdinler PH, Benn S, Yamamoto TH, Guzel M, Brown RH Jr, Macklis JD (2011) Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G(9)(3)A transgenic ALS mice. J Neurosci 31:4166–4177</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21411657</ArticleId>
            <ArticleId IdType="pmc">3643523</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4184-10.2011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menon P, Kiernan MC, Vucic S (2015) Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS. Clin Neurophysiol 126:803–809</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25227219</ArticleId>
            <ArticleId IdType="doi">10.1016/j.clinph.2014.04.023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashraf A, Fan Z, Brooks DJ, Edison P (2015) Cortical hypermetabolism in MCI subjects: a compensatory mechanism? Eur J Nucl Med Mol Imaging 42:447–458</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25267349</ArticleId>
            <ArticleId IdType="doi">10.1007/s00259-014-2919-z</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersen JV, Skotte NH, Christensen SK, Polli FS, Shabani M, Markussen KH, Haukedal H, Westi EW, Diaz-delCastillo M, Sun RC, Kohlmeier KA, Schousboe A, Gentry MS, Tanila H, Freude KK, Aldana BI, Mann M, Waagepetersen HS (2021) Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer’s disease. Cell Death Dis 12:954</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34657143</ArticleId>
            <ArticleId IdType="pmc">8520528</ArticleId>
            <ArticleId IdType="doi">10.1038/s41419-021-04237-y</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pieri M, Carunchio I, Curcio L, Mercuri NB, Zona C (2009) Increased persistent sodium current determines cortical hyperexcitability in a genetic model of amyotrophic lateral sclerosis. Exp Neurol 215:368–379</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19071115</ArticleId>
            <ArticleId IdType="doi">10.1016/j.expneurol.2008.11.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carunchio I, Curcio L, Pieri M, Pica F, Caioli S, Viscomi MT, Molinari M, Canu N, Bernardi G, Zona C (2010) Increased levels of p70S6 phosphorylation in the G93A mouse model of amyotrophic lateral sclerosis and in valine-exposed cortical neurons in culture. Exp Neurol 226:218–230</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20832409</ArticleId>
            <ArticleId IdType="doi">10.1016/j.expneurol.2010.08.033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finch CE, Felicio LS, Mobbs CV, Nelson JF (1984) Ovarian and steroidal influences on neuroendocrine aging processes in female rodents. Endocr Rev 5:467–497</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6389107</ArticleId>
            <ArticleId IdType="doi">10.1210/edrv-5-4-467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mobbs CV, Gee DM, Finch CE (1984) Reproductive senescence in female C57BL/6J mice: ovarian impairments and neuroendocrine impairments that are partially reversible and delayable by ovariectomy. Endocrinology 115:1653–1662</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6541567</ArticleId>
            <ArticleId IdType="doi">10.1210/endo-115-5-1653</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
